Contrary to this fact, in mouse models of cancer, the inhibition of TGFβ signaling with the expression of dominant-negative TβRII (DNRII) or deletion of TβRII increases cellular proliferation without initiating tumor development [3],[4]. This evidence concerns the gene TGFBR2 and neoplasm.